This duality in HMGB1 function during pyroptosis, whether promoting resistance through proliferative signaling and immunosuppression or enhancing sensitivity through immunogenic cell death, appears to depend on multiple factors including cancer type, genetic background, therapeutic agent, and the tumor microenvironment. This evidence concerns the gene HMGB1 and cancer.